title: Correlation between liver cancer pain and the HIF-1 and VEGF expression levels.
abstract: A possible correlation between liver cancer pain and the hypoxia-inducible factor (HIF)-1 and vascular endothelial growth factor (VEGF) expression levels was examined. From January, 2015 to January, 2016, 30 patients suffering from liver cancer with pain, 30 patients with liver cancer without pain and 30 hepatitis patients with pain were enrolled in the study. Pain level was evaluated by visual analogue scale (VAS), the expression levels of HIF-1 and VEGF mRNA were determined by RT-PCR and the expression levels of HIF-1 and VEGF proteins were examined by ELISA. Before intervention, the VAS in the hepatitis group was significantly higher than that of the liver cancer pain group. However, after intervention the VAS in the two groups was reduced. HIF-1 and VEGF mRNA expression levels in the liver cancer pain group were significantly higher than those in the liver cancer group before and after intervention. The expression levels of HIF-1 and VEGF mRNA in the hepatitis group were the lowest. The expression levels of HIF-1 and VEGF mRNA in the liver cancer pain group considerably increased after intervention. The expression levels of HIF-1 and VEGF mRNA in the other two groups showed no changes before or after intervention. Before and after the intervention, VAS in the liver cancer pain group was positively correlated to the expression levels of HIF-1 and VEGF. Thus, pain occurrence and the pain level in liver cancer patients were correlated with the expression levels of HIF-1 and VEGF. As the regular three-step medicine analgesic ladder is ineffective in these cases, verification of HIF-1 and VEGF expression levels may be considered the new target for pain release.
authors.affiliation: Department of Pain, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.
authors.forename: Geng
authors.initials: G
authors.lastname: Zhang
authors.affiliation: Department of Pain, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.
authors.forename: Gui-Yin
authors.initials: GY
authors.lastname: Feng
authors.affiliation: Department of Pain, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.
authors.forename: Yan-Ru
authors.initials: YR
authors.lastname: Guo
authors.affiliation: Department of Pain, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.
authors.forename: Dong-Qi
authors.initials: DQ
authors.lastname: Liang
authors.affiliation: Department of Pain, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.
authors.forename: Yuan
authors.initials: Y
authors.lastname: Yuan
authors.affiliation: Department of Pain, Cangzhou Central Hospital, Cangzhou, Hebei 061001, P.R. China.
authors.forename: Hai-Lun
authors.initials: HL
authors.lastname: Wang
keywords: correlation; hypoxia-inducible factor; liver cancer; pain; vascular endothelial growth factor; visual analogue scale